COSCIENS Biopharma, Inc. (CSCI.TO)
7.50
+0.26
(+3.59%)
CAD |
TSX |
Aug 25, 16:00
COSCIENS Biopharma Total Liabilities (Quarterly) : 5.688M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.688M |
| March 31, 2026 | 4.915M |
| December 31, 2025 | 24.11M |
| September 30, 2025 | 26.13M |
| June 30, 2025 | 27.92M |
| March 31, 2025 | 30.22M |
| December 31, 2024 | 31.51M |
| September 30, 2024 | 32.09M |
| June 30, 2024 | 32.59M |
| March 31, 2024 | 25.47M |
| December 31, 2023 | 3.573M |
| September 30, 2023 | 21.91M |
| June 30, 2023 | 23.03M |
| March 31, 2023 | 27.17M |
| December 31, 2022 | 27.44M |
| September 30, 2022 | 23.62M |
| June 30, 2022 | 22.61M |
| March 31, 2022 | 28.96M |
| December 31, 2021 | 34.25M |
| September 30, 2021 | 28.02M |
| June 30, 2021 | 28.49M |
| March 31, 2021 | 28.71M |
| December 31, 2020 | 30.31M |
| September 30, 2020 | 22.87M |
| June 30, 2020 | 22.80M |
| Date | Value |
|---|---|
| March 31, 2020 | 25.55M |
| December 31, 2019 | 29.10M |
| September 30, 2019 | 31.37M |
| June 30, 2019 | 31.07M |
| March 31, 2019 | 34.66M |
| December 31, 2018 | 37.58M |
| September 30, 2018 | 27.21M |
| June 30, 2018 | 29.10M |
| March 31, 2018 | 32.10M |
| December 31, 2017 | 38.20M |
| September 30, 2017 | 30.63M |
| June 30, 2017 | 25.99M |
| March 31, 2017 | 30.31M |
| December 31, 2016 | 34.13M |
| September 30, 2016 | 37.40M |
| June 30, 2016 | 36.38M |
| March 31, 2016 | 35.89M |
| December 31, 2015 | 41.51M |
| September 30, 2015 | 48.37M |
| June 30, 2015 | 59.72M |
| March 31, 2015 | 56.86M |
| December 31, 2014 | 38.17M |
| September 30, 2014 | 53.77M |
| June 30, 2014 | 46.75M |
| March 31, 2014 | 49.91M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spectral Medical, Inc. | 73.26M |
| Resverlogix Corp. | 145.46M |
| Theratechnologies, Inc. | 108.88M |
| Restart Life Sciences Corp. | 0.7405M |
| Defence Therapeutics Inc | 4.031M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.74M |
| Shareholders Equity (Quarterly) | 21.06M |
| Debt to Equity Ratio | 0.1318 |
| Current Ratio | 4.328 |
| Net Debt Paydown Yield | 0.83% |